VA
ACAD icon

Vident Advisory’s Acadia Pharmaceuticals ACAD Stock Holding History

Vident Advisory’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,179
Closed -$230K – 1409
2024
Q2 		$230K Buy
+14,179
New +$230K 0.01% 1225
2024
Q1 		– Sell
-7,279
Closed -$228K – 1324
2023
Q4 		$228K Buy
+7,279
New +$228K 0.01% 1152